Takeaway
Neurofilament light chain levels could be effective diagnostic and prognostic differential biomarkers in amyotrophic lateral sclerosis.
Why this matters?
Novel, more effective neurochemical biomarkers are needed to accurately predict diagnosis and prognosis in amyotrophic lateral sclerosis.
This unique integrated evaluation of a panel of neurochemical biomarkers reveals neurofilament light chain as a potential diagnostic and prognostic biomarker in differentiating amyotrophic lateral sclerosis from its mimic disorders.